Overcoming postcode discrimination for thoracic cancer patients
Overcoming postal code discrimination for thoracic cancer patients $3.5M
While 42 hospitals from Gaspé to Gatineau refer patients with complex thoracic cancers to the MUHC, survival rates are lower for those living outside of Montréal. Why? They don’t have local access to the latest treatments and higher quality of care available in clinical trials run in Montréal.
Trials require weekly scans and checkups to monitor disease progression. For most, it’s too far to travel and too expensive. Local community hospitals aren’t staffed to offer clinical trials to their patients.
Dr. Jonathan Spicer
Armen, a Security Guard at the Montreal General Hospital was a stage 3 lung cancer patient who enrolled in a successful clinical trial led by Dr. Spicer. He is now in remission.
“We see a huge opportunity to enable our network of referring hospitals to participate in these innovative trials to overcome these postal code disparities, improving outcomes and advancing scientific discovery.”
Dr. Jonathan Spicer
Thoracic Surgeon, MUHC
Medical Director, McGill Thoracic Oncology Network
More news
Giving Patients Back What Cancer Took Away
Plastic surgeon Dr. Josh Vorstenbosch, Director of the McGill University Health Centre (MUHC)’s Surgical Lymphedema Program, wants to “give patients back what cancer took away,” he says.
With over $50M raised, World Cancer Day sees us halfway to our goal. Help us reach $100M
On World Cancer Day 2024, the Cedars Cancer Foundation and the Montreal General Hospital Foundation launched our joint fundraising campaign, Together Against Cancer. Thanks to our generous donors, we’re halfway to our $100M fundraising goal.
Better Access to Clinical Trials Could Save the Lives of Cancer Patients
After coughing up blood one day, Armen, a security guard at the Montreal General Hospital (MGH-MUHC), was diagnosed with stage 3 lung cancer.